Skip to main content

Table 1 Patient characteristics

From: Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder

  All subjects N = 33
Mean age, years ± SD 46 ± 6.5
   Range 29–55
Sex, %  
   Women 85
   Men 15
Mean age at onset of PTSD, years ± SD 29 ± 15
   Range 2–53
Mean duration of PTSD history, years ± SD 18 ± 15
   Range 0–46
Patients with comorbid disorders, N (%)  
   Bipolar disorder 10 (30)
   Major depressive disorder 21 (64)
   Substance abuse  
Current 3 (9)
In past 5 (15)
  1. SD =standard deviation; PTSD = posttraumatic stress disorder.